Arecor Therapeutics (AREC) News Today GBX 45.25 -38.50 (-45.97%) As of 04:13 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock AREC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Arecor Therapeutics Strengthens Board with Key AppointmentsSeptember 29, 2025 | tipranks.comArecor Therapeutics to Announce Interim ResultsSeptember 25, 2025 | msn.comArecor Therapeutics (LON:AREC) Announces Earnings ResultsSeptember 25, 2025 | americanbankingnews.comArecor Therapeutics Advances Diabetes and Obesity Drug Development with Strategic PartnershipsSeptember 25, 2025 | tipranks.comTRADING UPDATES: Gem Resources raises funds; Afentra Angolan progressSeptember 4, 2025 | lse.co.ukArecor Therapeutics Secures FDA Approval for Innovative Insulin Study DesignSeptember 4, 2025 | msn.comLON:AREC Financials | Arecor Therapeutics PLC - Investing.comAugust 23, 2025 | investing.comArecor Therapeutics And 2 Other UK Penny Stocks To ConsiderJuly 31, 2025 | finance.yahoo.comArecor Therapeutics plc (LON:AREC) Insider Sarah Jennifer Howell Buys 21,077 SharesMay 22, 2025 | insidertrades.comSkye and Arecor to develop higher formulation of CB1 inhibitorMay 20, 2025 | finance.yahoo.comInsider Buying: Arecor Therapeutics plc (LON:AREC) Insider Purchases 35,000 Shares of StockMay 15, 2025 | insidertrades.comArecor Chair Increases Stake with Share PurchaseMay 14, 2025 | tipranks.comSMALL-CAP MOVERS: Is popping AIM ready to really blow up? One research house reckons soMay 10, 2025 | uk.investing.comSMALL CAP MOVERS: Is 'oversold' AIM market due a comeback story?May 9, 2025 | msn.comArecor Therapeutics Full Year 2024 Earnings: Misses ExpectationsApril 23, 2025 | finance.yahoo.comArecor Therapeutics strikes deal for development of peptide therapyMarch 12, 2025 | lse.co.ukArecor Partners to Innovate Peptide Therapy FormulationMarch 12, 2025 | tipranks.comArecor Full Year 2024 Trading UpdateFebruary 4, 2025 | lse.co.ukArecor Therapeutics confident for the future as revenue risesFebruary 3, 2025 | lse.co.ukArecor Therapeutics Shifts Strategy, Ceases Tetris Pharma OperationsJanuary 10, 2025 | tipranks.comMARKET REPORT: British blue chips set to end the year on a whimperDecember 31, 2024 | msn.comArecor inks licensing deal for AT351December 30, 2024 | uk.investing.comArecor Therapeutics Appoints New Interim CFO David EllamNovember 18, 2024 | msn.comArecor Therapeutics First Half 2024 Earnings: UK£0.15 loss per share (vs UK£0.15 loss in 1H 2023)September 28, 2024 | finance.yahoo.comEARNINGS: Hansard Global profit down; Flowtech cuts outlookSeptember 27, 2024 | lse.co.ukAt278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 DiabetesMay 20, 2024 | finance.yahoo.comArecor Therapeutics collaborates with Medtronic on novel insulinMay 9, 2024 | lse.co.ukArecor Therapeutics plc: Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump deliveryMay 9, 2024 | finanznachrichten.deArecor chief financial officer to leave in July after five yearsApril 23, 2024 | lse.co.ukArecor Therapeutics PLC Ordinary Shares ARECApril 18, 2024 | morningstar.comMStrip Tinning shares up as hails "largest ever" glazing orderApril 2, 2024 | lse.co.ukArecor Therapeutics announces collaboration on oral GLP-1 drug for diabetes and obesity treatmentMarch 14, 2024 | finance.yahoo.comArecor to develop "holy grail" diabetes treatment with partner TRxMarch 12, 2024 | lse.co.ukARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITYMarch 12, 2024 | finance.yahoo.comArecor Therapeutics plc (AREC.L)February 16, 2024 | finance.yahoo.comArecor Therapeutics hails Arestat as 2023 performance "strong"February 1, 2024 | lse.co.ukArecor Therapeutics PLC Ordinary SharesJanuary 20, 2024 | morningstar.comMTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsJanuary 18, 2024 | lse.co.ukArecor inks co-development deal with global medical companyDecember 4, 2023 | lse.co.ukArecor Therapeutics takes major step with first commercial sale of AT220November 17, 2023 | finance.yahoo.comTRADING UPDATES: Troy Income suspends buyback of sharesNovember 2, 2023 | lse.co.ukArecor Therapeutics subsidiary Tetris Pharma signs deal with GoodlifeSeptember 4, 2023 | lse.co.ukArecor Therapeutics to collaborate with "top 10" pharmaceutical firmAugust 17, 2023 | lse.co.ukArecor Therapeutics Flags Strong 1H ProgressJuly 20, 2023 | marketwatch.comArecor: Business UpdateJuly 20, 2023 | finance.yahoo.comShareholders in Arecor Therapeutics (LON:AREC) are in the red if they invested a year agoJune 3, 2023 | finance.yahoo.comArecor Therapeutics has "a strong basis to accelerate" growth strategyApril 24, 2023 | finance.yahoo.comRecent uptick might appease Arecor Therapeutics plc (LON:AREC) institutional owners after losing 16% over the past yearMarch 14, 2023 | finance.yahoo.comArecor to launch second Phase I clinical trial of AT278 rapid-acting insulin for diabetes patientDecember 1, 2022 | msn.comEven after rising 12% this past week, Arecor Therapeutics (LON:AREC) shareholders are still down 43% over the past yearNovember 10, 2022 | finance.yahoo.com Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AREC Media Mentions By Week AREC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AREC News Sentiment▼0.750.54▲Average Medical News Sentiment AREC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AREC Articles This Week▼00▲AREC Articles Average Week Get the Latest News and Ratings for AREC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arecor Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Bioventix News 4basebio News Scancell News Ondine Biomedical News ImmuPharma News Hemogenyx Pharmaceuticals News hVIVO News SkinBioTherapeutics News Sareum News Poolbeg Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AREC) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
